Table 1 Obstetric and thrombotic... | American Society of Hematology

Table 1

Obstetric and thrombotic histories and aPL of women before pregnancy treated with additional prednisolone

Patient	Previous Thrombo-embolism	Fetal loss at < 10 weeks: treatment			Fetal loss at > 10 weeks: treatment			IUGR	Preeclampsia	Live births; gestation	LA	Ig M ACA < 11MPL U/mL	Ig G ACA < 20.1GPL U/mL
Patient	Previous Thrombo-embolism	None	Aspirin	Aspirin/heparin	None	Aspirin	Aspirin/heparin	IUGR	Preeclampsia	Live births; gestation	LA	Ig M ACA < 11MPL U/mL	Ig G ACA < 20.1GPL U/mL
1	0	3	2	2	0	0	0	0	0	0	+	14.6	3.7
2	0	1	0	1	2	0	0	0	0	0	+	16.4	13.3
3	0	7	4	3	0	0	0	0	0	1; 28/40	+	9.8	70
4	1	0	0	2	1	0	0	0	1	1; 38/40	+	74	> 300
5	1	0	0	1	0	0	2; No aspirin*	0	0	0	+	6.5	30.8
6	3	1	0	5	0	0	0	1	1	1; 37/40	+	18	105
7	0	1	0	2	0	0	0	0	0	0	−	14.5	24.2
8	0	0	3	1	0	0	0	0	0	1†	+	26.2	7.2
9	0	6	1	1	0	0	0	0	0	0	+	7.5	11.5
10	0	2	0	2	0	0	0	0	0	0	+	5	18.4
11	1	0	0	0	0	0	1	0	0	0	‡	11.1	93.8
12	2	2	0	1	0	0	0	0	0	0	+	5.7	4.7
13	0	5	0	3	0	0	0	0	0	0	+	9.4	8.1
14	2	0	0	1	0	0	1	0	0	0	+	11.9	140
15	0	3	2	3	1	0	0	0	0	1; 40/40	−	13	9
16	0	2	0	2	0	0	0	0	0	0	−	32.7	79.2
17	0	2	1	2	1	0	0	0	0	0	−	15.5	3.3
18	0	3	0	1; Allergic to LMWH; limited use§	0	0	0	1; Aspirin; allergic to LMWH§	0	1; 40/40	+	1.5	1.1

Patient	Previous Thrombo-embolism	Fetal loss at < 10 weeks: treatment			Fetal loss at > 10 weeks: treatment			IUGR	Preeclampsia	Live births; gestation	LA	Ig M ACA < 11MPL U/mL	Ig G ACA < 20.1GPL U/mL
Patient	Previous Thrombo-embolism	None	Aspirin	Aspirin/heparin	None	Aspirin	Aspirin/heparin	IUGR	Preeclampsia	Live births; gestation	LA	Ig M ACA < 11MPL U/mL	Ig G ACA < 20.1GPL U/mL
1	0	3	2	2	0	0	0	0	0	0	+	14.6	3.7
2	0	1	0	1	2	0	0	0	0	0	+	16.4	13.3
3	0	7	4	3	0	0	0	0	0	1; 28/40	+	9.8	70
4	1	0	0	2	1	0	0	0	1	1; 38/40	+	74	> 300
5	1	0	0	1	0	0	2; No aspirin*	0	0	0	+	6.5	30.8
6	3	1	0	5	0	0	0	1	1	1; 37/40	+	18	105
7	0	1	0	2	0	0	0	0	0	0	−	14.5	24.2
8	0	0	3	1	0	0	0	0	0	1†	+	26.2	7.2
9	0	6	1	1	0	0	0	0	0	0	+	7.5	11.5
10	0	2	0	2	0	0	0	0	0	0	+	5	18.4
11	1	0	0	0	0	0	1	0	0	0	‡	11.1	93.8
12	2	2	0	1	0	0	0	0	0	0	+	5.7	4.7
13	0	5	0	3	0	0	0	0	0	0	+	9.4	8.1
14	2	0	0	1	0	0	1	0	0	0	+	11.9	140
15	0	3	2	3	1	0	0	0	0	1; 40/40	−	13	9
16	0	2	0	2	0	0	0	0	0	0	−	32.7	79.2
17	0	2	1	2	1	0	0	0	0	0	−	15.5	3.3
18	0	3	0	1; Allergic to LMWH; limited use§	0	0	0	1; Aspirin; allergic to LMWH§	0	1; 40/40	+	1.5	1.1

IUGR indicates intrauterine growth restriction; LA, lupus anticoagulant; ACA, anticardiolipin antibodies (IgM and IgG); and LMWH, low-molecular-weight heparin.

Intolerant of aspirin; therefore, LMWH alone was given.

†

Gestational age at delivery unavailable.

‡

Result not available.

Urticaria at injection sites with LMWH; therefore, LMWH was discontinued.

View Large

This Feature Is Available To Subscribers Only